Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharma Two B Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10649
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharma Two B Ltd (Pharma Two) is a drug development company that develops and manufactures drugs for the treatment of Parkinson’s disease and cancer. The company provides combination products in preclinical state and generic products including P2B 005, P2B 006, P2B 007, P2B 008 and P2B 009, among others. It provides products for pancreatic, lung and breast cancers, hyperphosphataemia, hyperphosphataemia, hyperlipidemia, secondary hyperparathyroidism and dry eye, among others. Pharma Two formulates products using tableting and microencapsulation techniques. The company develops combinations of two drugs and generic products. It also develops non-infringing formulations and complete research and development files such as formulations, analytical methods, stability, pilot studies, and others. The company markets products in global regions. Pharma Two is headquartered in Rehovot, Israel.

Pharma Two B Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pharma Two B Raises USD30 Million in Third Round of Financing 10
Pharma Two B Raises US$8 Million In Second Round Of Financing 11
Acquisition 12
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 12
Pharma Two B Ltd – Key Competitors 13
Pharma Two B Ltd – Key Employees 14
Pharma Two B Ltd – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Clinical Trials 16
Feb 06, 2018: First Patients Dosed in Phase III Multi-center, Multinational Study to Determine the Efficacy, Safety and Tolerability of P2B001 in Patients with Early Stage Parkinson’s Disease 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharma Two B Raises USD30 Million in Third Round of Financing 10
Pharma Two B Raises US$8 Million In Second Round Of Financing 11
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 12
Pharma Two B Ltd, Key Competitors 13
Pharma Two B Ltd, Key Employees 14

List of Figures
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharma Two B Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharma Two B Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korn Ferry (KFY):企業の財務・戦略的SWOT分析
    Korn Ferry (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EQT Corporation:企業の戦略・SWOT・財務情報
    EQT Corporation - Strategy, SWOT and Corporate Finance Report Summary EQT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Egypt Gas (EGAS):企業の財務・戦略的SWOT分析
    Summary Egypt Gas (EG) is oil and gas service contractor that offers distribution of natural gas and the implementation of natural gas projects. The company offers services such as mechanical works, supply and construction of pressure reduction and measurement units, suspended and buried gas pipelin …
  • Ornua Co-operative Limited:企業の戦略・SWOT・財務情報
    Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • NTPC Ltd (NTPC):企業の財務・戦略的SWOT分析
    NTPC Ltd (NTPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Circle Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Circle Pharma Inc. (Circle Pharma) is a drug development company that strives to develop cell permeable macrocyclic peptide therapies by combining computational design and synthetic chemistry. Its technology platform is applicable in a wide range of disease conditions such as fibrosis, infla …
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Oglethorpe Power Corporation:発電所・企業SWOT分析
    Oglethorpe Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Chr. Hansen Holding AS (CHR):製薬・医療:M&Aディール及び事業提携情報
    Summary Chr. Hansen Holding A/S (Chr. Hansen) is a bioscience company that focuses on the development of natural ingredient solutions for the food, pharmaceutical, nutritional and agricultural industries. The company develops, produces and markets cultures, enzymes, probiotics and natural colors. It …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …
  • Autolus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) t …
  • Renesola Ltd (SOL):電力:M&Aディール及び事業提携情報
    Summary Renesola Ltd (ReneSola) is a solar project developer and operator of energy efficient products that manufactures polysilicon, monocrystalline and multi crystalline solar wafers; and solar photovoltaic cells and modules. It also develops, builds and sells solar power projects across Europe, N …
  • Misen Energy AB (MISE):企業の財務・戦略的SWOT分析
    Summary Misen Energy AB (Misen) is an oil and gas company that provides pipeline services. The company offers production of gas and oil fields by implementation of large-scale investment programs and introduction of modern western knowhow and technology. It provides development of new and redevelopm …
  • Datatec Limited:企業の戦略・SWOT・財務分析
    Datatec Limited - Strategy, SWOT and Corporate Finance Report Summary Datatec Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SPR Therapeutics LLC:製品パイプライン分析
    Summary SPR Therapeutics LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes therapies for post-surgical pain, neuropathic pain, and musculoskeletal pain. It also provides pe …
  • Washington University in St Louis:製薬・医療:M&Aディール及び事業提携情報
    Summary Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisci …
  • Sojitz Corporation (2768)-石油・ガス分野:企業M&A・提携分析
    Summary Sojitz Corporation (Sojitz) is a diversified general trading group. The group through its subsidiaries and affiliates holds interest in machinery; energy and metals; chemicals and functional materials; and consumer lifestyle businesses. It distributes automobiles and aircraft; develops power …
  • CNX Resources Corp (CNX):企業の財務・戦略的SWOT分析
    CNX Resources Corp (CNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Neenah Inc:企業の戦略・SWOT・財務情報
    Neenah Inc - Strategy, SWOT and Corporate Finance Report Summary Neenah Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆